中文版 | English

在结果中检索

CCPortal

浏览/检索结果: 共35条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Tibetan highland barley fiber improves obesity and regulates gut microbiota in high-fat diet-fed mice 期刊论文
FOOD BIOSCIENCE, 2023, 卷号: 53
作者:  Gan, Linyao;  Han, Jing;  Li, Chenyao;  Tang, Jing;  Wang, Xuebing;  Ma, Yue;  Chen, Yefu;  Xiao, Dongguang;  Guo, Xuewu
收藏  |  浏览/下载：1/0  |  提交时间：2024/03/01
Gut microbiota  Highland barley  Fiber  Obesity  C57BL  6J mice  
Distinctive biochemistry profiles associated with hyperuricemia between Tibetans and Hans in China 期刊论文
FRONTIERS IN ENDOCRINOLOGY, 2023, 卷号: 14
作者:  Ren, Xue-Wen;  Chen, Kang;  Wu, Jue;  Yang, Zhang-Lin;  Ji, Tao;  Zhang, Qing-Hong
收藏  |  浏览/下载：6/0  |  提交时间：2024/03/01
Tibetan  hyperuricemia  hypoxia  glycolysis  aminotransferase  lipid metabolism  red blood cell  
Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China 期刊论文
DIABETOLOGY & METABOLIC SYNDROME, 2023, 卷号: 15, 期号: 1
作者:  Meng, Jinli;  Huang, Fangfang;  Shi, Jing;  Zhang, Chenghui;  Feng, Li;  Wang, Suyuan;  Li, Hengyan;  Guo, Yongyue;  Hu, Xin;  Li, Xiaomei;  He, Wanlin;  Cheng, Jian;  Wu, Yunhong
收藏  |  浏览/下载：5/0  |  提交时间：2024/03/01
Tibetan  Type 2 diabetes mellitus  Serum metabolomics  Machine learning  Biomarker  
The effect of short-term fine particulate matter exposure on glucose homeostasis: A panel study in healthy adults 期刊论文
ATMOSPHERIC ENVIRONMENT, 2022, 卷号: 268
作者:  Peng S.;  Sun J.;  Liu F.;  Li Z.;  Wu C.;  Xiang H.
收藏  |  浏览/下载：33/0  |  提交时间：2022/01/18
Glucose homeostasis  Insulin resistance  Panel study  Personal exposure  PM2.5  
Link Between Long-Term Exposure to Air Pollution and Fatty Liver Disease Shown 科技资讯
2021
收藏  |  浏览/下载：20/0  |  提交时间：2021/12/08
Decades After Toxic Exposure, 9/11 First Responders May Still Lower Their Risk of Lung Injury 科技资讯
2021
收藏  |  浏览/下载：0/0  |  提交时间：2021/09/03
Answers to these botanical mysteries could help a climate-stressed world 科技资讯
2021
收藏  |  浏览/下载：16/0  |  提交时间：2021/06/16
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Ji L.;  Song W.;  Fang H.;  Li W.;  Geng J.;  Wang Y.;  Guo L.;  Cai H.;  Yang T.;  Li H.;  Yang G.;  Li Q.;  Liu K.;  Li S.;  Liu Y.;  Shi F.;  Li X.;  Gao X.;  Tian H.;  Ji Q.;  Su Q.;  Zhou Z.;  Wang W.;  Zhou Z.;  Li X.;  Xu Y.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Jia W.
收藏  |  浏览/下载：35/0  |  提交时间：2021/09/01
Carfloglitazar  Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes  
Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis 期刊论文
Proceedings of the National Academy of Sciences of the United States of America, 2021, 卷号: 118, 期号: 5
作者:  Price N.L.;  Zhang X.;  Fernández-Tussy P.;  Singh A.K.;  Burnap S.A.;  Rotllan N.;  Goedeke L.;  Sun J.;  Canfrán-Duque A.;  Aryal B.;  Mayr M.;  Suárez Y.;  Fernández-Hernando C.
收藏  |  浏览/下载：42/0  |  提交时间：2021/05/24
An integrative transcriptional logic model of hepatic insulin resistance 期刊论文
Proceedings of the National Academy of Sciences of the United States of America, 2021, 卷号: 118, 期号: 45
作者:  Kitamoto T.;  Kuo T.;  Okabe A.;  Kaneda A.;  Accili D.
收藏  |  浏览/下载：18/0  |  提交时间：2022/02/22